These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Mechanism of action of arenesulfonylhydrazones of 2-pyridinecarboxaldehyde 1-oxide in L1210 cells.
    Author: Shiba DA, Cosby LA, Sartorelli AC.
    Journal: Cancer Res; 1984 Dec; 44(12 Pt 1):5707-11. PubMed ID: 6498834.
    Abstract:
    The arenesulfonylhydrazones of 2-pyridinecarboxaldehyde 1-oxide represent a relatively new class of anticancer agents. The biochemical alterations responsible for antineoplastic activity were investigated using the most potent member of this class synthesized to date, the 3,4-dimethoxybenzenesulfonylhydrazone of 2-pyridinecarboxaldehyde 1-oxide (3,4-DSP), as the prototype compound. The primary biochemical lesion observed was the production of DNA single-strand breaks, which were analyzed using alkaline elution methodology. This production of DNA damage required the spontaneous chemical formation of a reactive species; thus, "aging" of a solution of 3,4-DSP prior to exposure of L1210 leukemia cells in culture markedly decreased the production of DNA single-strand breaks. The chemical production of an alkylating species from 3,4-DSP has been proposed to occur by the intramolecular abstraction of the nitrogen proton by the 1-oxide group, followed by release of arenesulfinic acid to form the potent alkylating species, 1-oxidopyridin-2-yldiazomethane. Replacement of the proton by a methyl group, lack of the 1-oxide group, or replacement of the aldehyde proton by a methyl group increases the chemical stability of the arenesulfonylhydrazones. These modifications have been shown in a previous publication (D .A. Shiba, J. A. May, Jr., and A. C. Sartorelli, Cancer Res., 43: 2023-2029, 1983) to lead to (a) an elimination of alkylating activity and (b) a decrease in in vitro cytotoxicity and in vivo anticancer activity. These effects are also accompanied by an inability to produce detectable DNA single-strand breaks. 3,4-DSP caused little or no inhibition of the biosyntheses of DNA, RNA, or protein, as measured by the incorporation of radiolabeled thymidine, uridine, or leucine, respectively, into acid-insoluble material; however, consistent with the production of DNA damage, 3,4-DSP inhibited the normal progression of L1210 cells through the cell cycle after a single treatment in vivo with drug (100 mg/kg). Cells were blocked in the G2-M phase of the cell cycle for 6 to 24 hr after exposure to 3,4-DSP; the cell population recovered by 48 hr after exposure and appeared to be progressing normally through the cell cycle.
    [Abstract] [Full Text] [Related] [New Search]